| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
3,780,000 |
| Market
Cap: |
11.68(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.49 - $3.36 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile AYTU BioPharma is a pharmaceutical company focused on commercializing therapeutics and consumer health products and developing therapeutics for pediatric-onset or difficult-to-treat diseases. Co. operates through two business segments: the BioPharma segment, consisting of prescription pharmaceutical products; and the Consumer Health segment, which consists of various consumer healthcare products. Co. also has two product candidates in development, AR101 (enzastaurin) for the treatment of vascular Ehlers-Danlos Syndrome and Healight (endotracheal ultraviolet light catheter) for the treatment of severe, difficult-to-treat respiratory infections.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
14,000 |
538,371 |
| Total Buy Value |
$0 |
$0 |
$26,079 |
$148,920 |
| Total People Bought |
0 |
0 |
1 |
3 |
| Total Buy Transactions |
0 |
0 |
1 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Disbrow Jarrett |
Chief Operating Officer |
• – – |
2016-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
48,184 |
246,838 |
|
- |
|
| Donofrio John Jr. |
Director |
– • – |
2016-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
65,000 |
|
- |
|
| Cantrell Gary |
Director |
– • – |
2016-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
65,000 |
|
- |
|
| Gould Gregory A |
Chief Financial Officer |
• – – |
2016-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
165,000 |
165,000 |
|
- |
|
| Macaluso Michael |
Director |
– • – |
2016-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
94,780 |
|
- |
|
| Mcgrael Jonathan H |
VP of Commercial Operations |
• – – |
2016-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
140,000 |
140,000 |
|
- |
|
| Disbrow Jarrett |
Chief Operating Officer |
• – – |
2016-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
165,000 |
198,654 |
|
- |
|
| Dockery Carl |
Director |
– • – |
2016-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
65,000 |
|
- |
|
| Disbrow Joshua R. |
Chief Executive Officer |
• – – |
2016-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
190,000 |
223,654 |
|
- |
|
| Disbrow Jarrett |
Chief Operating Officer |
• – – |
2016-05-06 |
4 |
B |
$0.40 |
$100,000 |
D/D |
250,000 |
403,846 |
2.74 |
- |
|
| Disbrow Joshua R. |
Chief Executive Officer |
• – – |
2016-05-06 |
4 |
B |
$0.40 |
$100,000 |
D/D |
250,000 |
403,846 |
2.74 |
- |
|
| Dockery Carl |
Director |
– • – |
2016-05-06 |
4 |
B |
$0.40 |
$2,000,000 |
I/I |
5,000,000 |
5,047,591 |
2.1 |
- |
|
| Dockery Carl |
Director |
– • – |
2016-04-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
47,591 |
|
- |
|
| Disbrow Jarrett |
Chief Operating Officer |
• – – |
2016-01-20 |
4 |
B |
$0.65 |
$100,000 |
D/D |
153,846 |
153,846 |
2.74 |
- |
|
| Disbrow Joshua R. |
Chief Executive Officer |
• – – |
2016-01-20 |
4 |
B |
$0.65 |
$100,000 |
D/D |
153,846 |
153,846 |
2.74 |
- |
|
| Ampio Pharmaceuticals, Inc. |
10% Owner |
– – • |
2015-12-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,399,661) |
1,226,407 |
|
- |
|
116 Records found
|
|
Page 5 of 5 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.06 (1.98%) 
